Clinical trials
Completed Observational trials in Poland
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
692 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 2 |
| 2002 | 1 |
| 2003 | 6 |
| 2004 | 6 |
| 2005 | 4 |
| 2006 | 17 |
| 2007 | 24 |
| 2008 | 15 |
| 2009 | 23 |
| 2010 | 38 |
| 2011 | 27 |
| 2012 | 27 |
| 2013 | 29 |
| 2014 | 36 |
| 2015 | 36 |
| 2016 | 31 |
| 2017 | 38 |
| 2018 | 50 |
| 2019 | 43 |
| 2020 | 51 |
| 2021 | 57 |
| 2022 | 44 |
| 2023 | 38 |
| 2024 | 32 |
| 2025 | 12 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 692 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Jagiellonian University | 41 |
| Medical University of Warsaw | 34 |
| Bayer | 24 |
| Medical University of Silesia | 23 |
| Medical University of Gdansk | 19 |
| Hoffmann-La Roche | 18 |
| Poznan University of Medical Sciences | 16 |
| Medical University of Lodz | 15 |
| Medical University of Lublin | 15 |
| Poznan University of Physical Education | 15 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Coronary Artery Disease | 20 |
| Stroke | 20 |
| Atrial Fibrillation | 19 |
| COVID-19 | 19 |
| Heart Failure | 19 |
| Diabetes Mellitus, Type 2 | 14 |
| Hypertension | 14 |
| Breast Neoplasms | 13 |
| Multiple Sclerosis | 13 |
| Cardiovascular Diseases | 12 |
Trials
Showing 1 to 25 of 692. Each trial links to its page on Pharma Observatory.
592 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.